S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll‐like receptor 4
David Rohde(Harvard University), Patrick Most(Thomas Jefferson University), Ieva Didrihsone(Heidelberg University), Björn Linke(German Cancer Research Center), Mirko Völkers(Heidelberg University), Evangelos Giannitsis(Heidelberg University), James N. Tsoporis(St. Michael's Hospital), Mona Mähler(Heidelberg University), Erhe Gao(Temple University), Hugo A. Katus(Heidelberg University), Christoph Schön(Heidelberg University), Karsten Peppel(Thomas Jefferson University), Katharina F. Kubatzky(Society for Chemical Engineering and Biotechnology), Nicole Herzog(Heidelberg University), Julia Ritterhoff(Heidelberg University), Thomas G. Parker(St. Michael's Hospital), Melanie Boerries(University of Freiburg)
Cited by 84
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k
Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration
|Nature Neuroscience|2018|583